Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 9, 2008
Yesterday saw heavy trading in Boston Scientific's (NYSE: BSX) stock, with approximately 38 million shares traded. This trading included involuntary...
-
Oct 8, 2008
Boston Scientific (NYSE: BSX) announced today it expects to record the following adjustments to its third quarter results, which it plans to report...
-
Oct 8, 2008PERSEUS clinical program to evaluate TAXUS® Element™ Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the PERSEUS trial, designed to evaluate the Company's...
-
Oct 1, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court in Delaware has entered judgment against the Company...
-
Sep 25, 2008Company also announces FDA approval of TAXUS® Express2™ Stent System for treatment of in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market...
-
Sep 19, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22...
-
Sep 15, 2008
Boston Scientific Corporation (NYSE: BSX) announced today a decision by the United States District Court in Delaware. The case involves a patent...
-
Sep 9, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America 38th Annual Investment Conference which is being held...